Is iron treatment beneficial in, irondeficient but nonanaemic (IDNA) endurance athletes? A systematic review and metaanalysis

British Journal of Sports Medicine

Volumn 49, Issue 21, 2015, Pages 1389-1397

  Burden, Richard J ^a   Morton, Katie ^a   Richards, Toby ^b   Whyte, Gregory P ^c   Pedlar, Charles R ^a  

^a ST MARY'S UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IRON;

ATHLETIC PERFORMANCE; DEFICIENCY; DRUG ADMINISTRATION ROUTE; ENDURANCE; FEMALE; HUMAN; MALE; META ANALYSIS; METABOLISM; PHYSIOLOGY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ATHLETIC PERFORMANCE; DRUG ADMINISTRATION ROUTES; FEMALE; HEMOGLOBINS; HUMANS; IRON; MALE; PHYSICAL ENDURANCE; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 84945192028     PISSN: 03063674     EISSN: 14730480     Source Type: Journal    
DOI: 10.1136/bjsports-2014-093624     Document Type: Review

References (64)

1. Beard J, Tobin B. Iron status and exercise. Am J Clin Nutr 2000;72:594-7S.
2. Suominen P, Punnonen K, Rajamaki A, et al. Serum transferrin receptor and transferrin-receptor index identify healthy subjects with subclinical iron deficits. Blood 1998;92:2934-9.
3. Garvican LA, Lobigs L, Telford R, et al. Haemoglobin mass in an anaemic female endurance runner before and after iron supplementation. Int J Sports Physiol Perform 2011;6:137-40.
4. Newhouse IJ, Clement DB, Taunton JE, et al. The effects of prelatent/latent iron deficiency on physical work capacity. Med Sci Sports Exerc 1989;21:263-8.
5. Zhu YI, Haas JD. Altered metabolic response of iron-depleted nonanaemic women during a 15-km time trial. J Appl Physiol 1998;84:1768-75.
6. Willis WT, Brooks GA, Henderson SA, et al. Effects of iron deficiency and training on mitochondrial enzymes in skeletal muscle. J Appl Physiol 1987;62:2442-6.
7. Haas J, Brownlie T IV. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship. J Nutr 2001;131:676S-88S.
8. Brownlie T, Utermohlen V, Hinton PS, et al. Tissue iron deficiency without anaemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004;79:437-43.
9. DellaValle DM, Haas JD. Impact of iron depletion without anaemia on performance in trained endurance athletes at the beginning of a training season: A study of female collegiate rowers. Int J Sport Nutr Exerc Metab 2011;21:501-6.
10. DellaValle DM, Haas JD. Iron status is associated with endurance performance and training in female rowers. Med Sci Sports Exerc 2012;44:1552-9.
11. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-3.
12. Richards T. Anaemia in hospital practice. Br J Hosp Med (Lond) 2012;73:571-5.
13. Bolger AP, Bartlett FR, Penston HS, et al. Intravenous iron alone for the treatment of anaemia in patients with chronic heart failure. J Am Coll Cardiol 2006;48:1225-7.
14. Cuenca J, Garcia-Erce JA, Munoz M, et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004;44:1447-52.
15. Gaber R, Kotb NA, Ghazy M, et al. Tissue Doppler and strain rate imaging detect improvement of myocardial function in iron deficient patients with congestive heart failure after iron replacement therapy. Echocardiography 2012;29:13-18.
16. Theusinger OM, Leyvraz PF, Schanz U, et al. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 2007;107:923-7.
17. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-6.
18. Peeling P, Blee T, Goodman C, et al. Effect of iron injections on aerobic-exercise performance of iron-depleted female athletes. Int J Sport Nutr Exerc Metab 2007;17:221-31.
19. Blee T, Goodman C, Dawson B, et al. The effect of intramuscular iron injections of serum ferritin levels and physical performance in elite netballers. J Sci Med Sport 1999;2:311-21.
20. Garvican LA, Saunders PU, Cardoso T, et al. Intravenous iron supplementation in distance runners with low or suboptimal ferritin. Med Sci Sports Exerc 2014;46:376-85.
21. Pedlar CR, Whyte GP, Burden RJ, et al. A case study of an iron deficient female Olympic 1500-m runner. Int J Sports Physiol Perform 2013;8:695-8.
22. Fogelholm M, Jaakkola L, Lampisjarvt T. Effects of iron supplementation in female athletes with low serum ferritin concentration. Int J Sports Med 1992;13:158-62.
23. Friedman B, Weller E, Mairbauri H, et al. Effects of iron repletion on blood volume and performance capacity in young athletes. Med Sci Sports Exerc 2001;33:741-6.
24. Hinton PS, Giordano C, Brownlie T, et al. Iron supplementation improves endurance after training in iron-depleted, nonanaemic women. J Appl Physiol 2000;88:1103-11.
25. Hinton PS, Sinclair LM. Iron supplementation maintains ventilatory threshold and improves energetic efficiency in iron-deficient nonanaemic athletes. Eur J Clin Nutr 2007;61:30-9.
26. Klingshirn LA, Pate RR, Bourque SP, et al. Effect of iron supplementation on endurance capacity in iron-depleted female runners. Med Sci Sports Exerc 1992;24:819-24.
27. LaManca JJ, Haymes EM. Effects of iron repletion on VO2max, endurance, and blood lactate in women. Med Sci Sports Exerc 1993;25:1386-92.
28. Magazanik A, Weinstein Y, Abarbanel J, et al. Effect of an iron supplement on body iron status and aerobic capacity of young training women. Eur J Appl Occup Physiol 1991;62:317-23.
29. Matter M, Stittfall T, Graves J, et al. The effect of iron and folate therapy on maximal exercise performance in female marathon runners with iron and folate therapy. Clin Sci (Lond) 1987;72:415-22.
30. Pattini A, Schena F. Effects of training and iron supplementation on iron status of cross-country skiers. J Sports Med Phys Fitness 1990;30:347-53.
31. Powell PD, Tucker A. Iron supplementation and running performance in female cross-country runners. Int J Sports Med 1991;13:158-62.
32. Radjen L, Radjen G, Zivotic-Vanovic M, et al. Effect of iron supplementation on maximal oxygen uptake in female athletes. Vojnosanit Pregl 2011;68:130-5.
33. Schoene RB, Escourrou P, Robertson T, et al. Iron repletion decreases maximal exercise lactate concentrations in female athletes with minimal iron-deficiency anaemia. J Lab Clin Med 1983;102:306-12.
34. Tsalis G, Nikolaidis MG, Mougios V. Effects of iron intake through food or supplement on iron status and performance of healthy adolescent swimmers during a training season. Int J Sports Med 2004;25:306-13.
35. Walsh R, McNaughton L. Effects of iron supplementation on iron status of young female swimmers during the pre-season phase of competition. J Swimming Res 1989;5:13-18.
36. Evstatiev R, Marteau P, Iqbal T, et al; FERGI Study Group. A randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease. Gastroenterology 2011;141:846-53.
37. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley Blackwell, 2008:187-242.
38. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol 2007;69:69-85.
39. Donovan A, Roy CN, Andrews NC. The ins and outs of iron homeostasis. Physiology 2006;21:115-23.
40. Peeling P, Dawson B, Goodman C, et al. Athletic induced iron deficiency: new insights into the role of inflammation, cytokines and hormones. Eur J Appl Physiol 2008;103:381-91.
41. Peeling P, Dawson B, Goodman C, et al. Effects of exercise on hepcidin response and iron metabolism during recovery. Int J Sport Nutr Exerc Metab 2009;19:583-97.
42. Peeling P. Exercise as a mediator of hepcidin activity in athletes. Eur J Appl Physiol 2010;110:877-83.
43. Martinovic J, Dopsaj V, Kotur-Stevuljevic J, et al. Oxidative stress status in elite female volleyball athletes with depleted iron stores. Br J Sports Med 2011;45:534-5.
44. Hopkins WG, Marshall SW, Batterham AM, et al. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc 2009;41:3-12.
45. Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 2006;1:S4-8.
46. Borel MJ, Smith SM, Der J, et al. Day-to-day variation in iron-status indices in healthy men and women. Am J Clin Nutr 1991;54:729-35.
47. Malczewska-Lenczowska J, Stupnicki R, Gabrys T. Effects of exercise on the markers of iron status in serum of cross-country skiers. Sports Biol 2010;27:241-7.
48. Schumacher YO, Schmid A, Konig D, et al. Effects of exercise on soluble transferrin receptor and other variables of the iron status. Br J Sports Med 2002;36:195-200.
49. Spiropoulos A, Goussetis E, Margeli A. Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis. Clin Chem Lab Med 2010;48:199-203.
50. Fillet G, Beguin Y. Monitroing of erythropoiesis by serum transferrin receptor and erythropoietin. Acta Clin Belg 2006;56:146-54.
51. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003;329:9-22.
52. DellaValle DM, Haas JD. Iron supplementation improves energetic efficiency in iron-depleted female rowers. Med Sci Sports Exerc 2014;46:1204-15.
53. Prommer N, Sottas P, Schoch C, et al. Total haemoglobin mass-a new parameter to detect blood doping? Med Sci Sports Exerc 2008;40:2112-18.
54. Pasricha SR, Low M, Thompson J, et al. Iron supplementation benefits physical performance in women of reproductive age: a systematic review and meta-analysis J Nutr 2014;144:906-14.
55. Ganzoni AM. New aspects of iron deficiency. Schweiz Med Wochenschr 1970;100:691-7.
56. Chertow G, Mason PD, Vaage-Nilsen O, et al. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2009;21:378-82.
57. Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anaemia in inflammatory bowl disease. The ferric carboxymaltose (FERINJECT) randomised controlled trial. Am J Gastroenterol 2007;102:1-11.
58. Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose. A review of its use in iron-deficiency anaemia. Drugs 2009;69:739-56.
59. Sim M, Dawson B, Landers G, et al. Iron regulation in athletes: Exploring the menstrual cycle and effects of different exercise modalities on hepcidin production. Int J Sport Nutr Exerc Metab. 2014;24:177-87.
60. Frassinelli-Gunderson EP, Margen S, Brown JR. Iron stores in users of oral contraceptive agents. Am J Clin Nutr 1985;41:703-12.
61. Milman N, Kirchhoff M, Jorgensen T. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment. Ann Hematol 1992;65:96-102.
62. Larsson G, Milsom L, Lindstedt G, et al. The influence of a low-dose combined oral contraceptive on menstrual blood loss and iron status. Contraception 1992;46:327-34.
63. Yang Q, Jian J, Katz S, et al. 17β-estradiol inhibits iron Hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012;153:3170-8.
64. Malcovati L, Pascotto C, Cazzola M. Hematologic passport for athletes competing in endurance sports: a feasibility study. Haematologica 2003;88:570-81.